- Home
- ZLAB vs NXE Comparison
ZLAB vs NXE Comparison
Compare ZLAB & NXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- NXE
- Stock Information
- Founded
- ZLAB 2013
- NXE 2011
- Country
- ZLAB China
- NXE Canada
- Employees
- ZLAB N/A
- NXE N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- NXE
- Sector
- ZLAB Health Care
- NXE
- Exchange
- ZLAB Nasdaq
- NXE Nasdaq
- Market Cap
- ZLAB 3.6B
- NXE 4.1B
- IPO Year
- ZLAB 2017
- NXE N/A
- Fundamental
- Price
- ZLAB $30.14
- NXE $6.17
- Analyst Decision
- ZLAB Buy
- NXE
- Analyst Count
- ZLAB 4
- NXE 0
- Target Price
- ZLAB $47.37
- NXE N/A
- AVG Volume (30 Days)
- ZLAB 944.8K
- NXE 9.3M
- Earning Date
- ZLAB 05-08-2025
- NXE 05-13-2025
- Dividend Yield
- ZLAB N/A
- NXE N/A
- EPS Growth
- ZLAB N/A
- NXE N/A
- EPS
- ZLAB N/A
- NXE N/A
- Revenue
- ZLAB $418,326,000.00
- NXE N/A
- Revenue This Year
- ZLAB $44.07
- NXE N/A
- Revenue Next Year
- ZLAB $49.13
- NXE N/A
- P/E Ratio
- ZLAB N/A
- NXE N/A
- Revenue Growth
- ZLAB 43.72
- NXE N/A
- 52 Week Low
- ZLAB $16.01
- NXE $3.91
- 52 Week High
- ZLAB $39.77
- NXE $8.96
- Technical
- Relative Strength Index (RSI)
- ZLAB 46.27
- NXE 66.00
- Support Level
- ZLAB $30.11
- NXE $5.35
- Resistance Level
- ZLAB $31.34
- NXE $6.60
- Average True Range (ATR)
- ZLAB 1.09
- NXE 0.25
- MACD
- ZLAB 0.07
- NXE 0.06
- Stochastic Oscillator
- ZLAB 43.07
- NXE 67.18
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About NXE Nexgen Energy Ltd.
NexGen Energy Ltd is a mineral exploration company. It is engaged in the acquisition, exploration, evaluation and development of uranium properties in Canada. The company's projects portfolio consists of ROOK I, and the IsoEnergy, at the Athabasca Basin. The Rook I property hosts the world-class Arrow Zone, the Bow discovery. as well as the discovered Harpoon area located northeast of the Arrow deposit.